i-spy2.2: emerging biomarkers in breast cancer
Published 1 year ago • 173 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
1:46
i-spy 2: advancing outcomes high-risk breast cancer through adapting therapies
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
1:39
using single cell technologies to identify biomarkers for breast cancer patient outcomes
-
1:39
new biomarker imaging techniques to improve mk-2206 efficacy in breast cancer
-
0:58
dr. esserman discusses the i-spy 2 trial in breast cancer
-
1:56
dr. esserman on the elements of the i-spy 2 trial in breast cancer
-
2:18
emerging biomarkers in lung cancer
-
2:01
i-spy 2 clinical trial for patients with stage 2 or 3 breast cancer
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
32:31
precision medicine in early stage breast cancer: the i-spy 2 experience: pgx conference 2018
-
1:19
predicting mk-2206 response in patients with breast cancer
-
22:42
paula pohlmann - precision medicine in the treatment of patients with breast cancer: i-spy trials
-
12:53
explanatory video about the i-spy 2 breast cancer clinical trial
-
1:06
dr. esserman on the basis for the i-spy 2 trial in breast cancer
-
5:22
i-spy 2 press conference
-
14:29
i-spy trial: precision medicine and biomarket discovery for early stage breast cancer, by julia wulf
-
3:16
the discovery of new biomarkers for predicting outcomes in breast cancer
-
1:00
the role of biomarkers in patients with breast cancer